Literature DB >> 7853548

Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer.

P D Lui1, M K Terris, J E McNeal, T A Stamey.   

Abstract

Transrectal prostate ultrasound and systematic sextant biopsies have improved peripheral zone cancer diagnosis but they may miss many cancers arising in the transition zone. Biopsies directed into the transition zone have been used to detect residual prostate cancer in patients diagnosed by transurethral resection and they have been suggested as potentially useful additions to systematic sextant biopsies. To define the indications for transition zone biopsies 187 men underwent evaluation including systematic sextant biopsies and transition zone biopsies. These patients were classified into 4 categories based on clinical presentation. Category 1 included 26 men with palpable nodularity and an elevated prostate specific antigen (PSA), of whom 16 (61.5%) had positive biopsies but none was positive only in the transition zone biopsies. Category 2 consisted of 49 men with sonographic abnormalities in the transition zone, of whom 15 (30.6%) had positive biopsies, including 2 (13.3%) with only positive transition zone biopsies. Category 3 consisted of 65 men with normal rectal examination and elevated PSA level, of whom 24 (36.9%) had biopsies positive for cancer, including 8 (33.3%) with only positive transition zone biopsies. Category 4 consisted of 47 men with a clinical presentation highly suspicious of prostatic malignancy but no cancer on prior systematic sextant biopsies, of whom 17 (37.7%) had positive biopsies, including 9 (53.0%) with only positive transition zone biopsies. We conclude that transition zone biopsies are useful in patients with a high suspicion of prostate cancer and negative prior systematic sextant biopsies. Cancer can also be demonstrated in many men with a normal digital rectal examination and an elevated PSA level. Patients with transition zone abnormalities on ultrasound images or palpable nodularity do not have substantially increased cancer detection with the addition of transition zone biopsies.

Entities:  

Mesh:

Year:  1995        PMID: 7853548

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Prostate biopsy: targeting cancer for detection and therapy.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2006

2.  Optimizing prostate biopsy strategies for the diagnosis of prostate cancer.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2003

3.  Urology Update from Jackson Hole: Highlights from the 3rd Annual Jackson Hole Summer Urologic Conference July 28-August 3, 2001, Jackson Hole, WY.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2002

4.  The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique.

Authors:  Saadettin Yilmaz Eskicorapci; Fuad Guliyev; Ekrem Islamoglu; Ali Ergen; Haluk Ozen
Journal:  Int Urol Nephrol       Date:  2006-06-01       Impact factor: 2.370

Review 5.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

6.  Optimal prostate biopsy regimen.

Authors:  Ryan K Berglund; J Stephen Jones
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

Review 7.  [Transrectal ultrasound-guided punch biopsies of the prostate. Indication, technique, results, and complications].

Authors:  J Palisaar; T Eggert; M Graefen; A Haese; H Huland
Journal:  Urologe A       Date:  2003-09       Impact factor: 0.639

Review 8.  A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck
Journal:  Int Urol Nephrol       Date:  2009-06-03       Impact factor: 2.370

9.  Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy.

Authors:  Katia Ramos Moreira Leite; Luiz Heraldo Camara-Lopes; José Cury; Marcos F Dall'oglio; Adriana Sañudo; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.